The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples
Open accessAbstract
Rationale: Despite improved understanding of the underlying genetics, pulmonary arterial hypertension (PAH) remains a severe disease. Extensive remodeling of small pulmonary arteries, including proliferation of pulmonary artery smooth muscle cells (PASMCs), characterizes PAH. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to play a role in vascular remodeling. Objective: We assessed the role of miR-145 in PAH. Methods and Results: We localized miR-145 in mouse lung to smooth muscle. Using quantitative PCR, we demonstrated increased expression of miR-145 in wild-type mice exposed to hypoxia. PAH was evaluated in miR-145 knockout and mice treated with anti-miRs via measurement of systolic right ventricular pressure, right ventricular hypertrophy, and percentage of remodeled pulmonary arteries. miR-145 deficiency and anti-miR–mediated reduction resulted in significant protection from the development of PAH. In contrast, miR-143 anti-miR had no effect. Furthermore, we observed upregulation of miR-145 in lung tissue of patients with idiopathic and heritable PAH compared with unaffected control subjects and demonstrated expression of miR-145 in SMC of remodeled vessels from such patients. Finally, we show elevated levels of miR-145 expression in primary PASMCs cultured from patients with BMPR2 mutations and also in the lungs of BMPR2 -deficient mice. Conclusions: miR-145 is dysregulated in mouse models of PAH. Downregulation of miR-145 protects against the development of PAH. In patient samples of heritable PAH and idiopathic PAH, miR-145 is expressed in remodeled vessels and mutations in BMPR2 lead to upregulation of miR-145 in mice and PAH patients. Manipulation of miR-145 may represent a novel strategy in PAH treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T.-H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009) · Nature · doi:10.1038/nature08195 · Cited by 1,585
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,305
SMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,124
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
A new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750
Frzb-1 Is a Secreted Antagonist of Wnt Signaling Expressed in the Spemann Organizer
Leyns, L., Bouwmeester, T., Kim, S.-H., Piccolo, S., & De Robertis, E. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81921-2 · Cited by 736
Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D.-Z., Lu, Q., Deitch, E. A., Huo, Y., Delphin, E. S., & Zhang, C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197517 · Cited by 657
Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L., & Braun, T. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38864 · Cited by 651
Xin, M., Small, E. M., Sutherland, L. B., Qi, X., McAnally, J., Plato, C. F., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2009) · Genes & Development · doi:10.1101/gad.1842409 · Cited by 649
Self-citationElia, L., Quintavalle, M., Zhang, J., Contu, R., Cossu, L., Latronico, M. V. G., Peterson, K. L., Indolfi, C., Catalucci, D., Chen, J., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.153 · Cited by 560
Role for miR-204 in human pulmonary arterial hypertension
Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101812 · Cited by 523
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Self-citationKano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y., Chiyomaru, T., Enokida, H., Nakagawa, M., & Matsubara, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25284 · Cited by 441
Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P. D., Jeffery, T. K., Atkinson, C., Chen, H., Trembath, R. C., & Morrell, N. W. (2005) · Circulation Research · doi:10.1161/01.res.0000166926.54293.68 · Cited by 364
Self-citationCaruso, P., MacLean, M. R., Khanin, R., McClure, J., Soon, E., Southgate, M., MacDonald, R. A., Greig, J. A., Robertson, K. E., Masson, R., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202028 · Cited by 336
Self-citationTeichert-Kuliszewska, K., Kutryk, M. J. B., Kuliszewski, M. A., Karoubi, G., Courtman, D. W., Zucco, L., Granton, J., & Stewart, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000200180.01710.e6 · Cited by 331
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
Jeffery, T. K., & Morrell, N. W. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.130041 · Cited by 317
Self-citationMandegar, M., Fung, Y.-C. B., Huang, W., Remillard, C. V., Rubin, L. J., & Yuan, J. X.-J. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.06.001 · Cited by 293
Davis-Dusenbery, B. N., Chan, M. C., Reno, K. E., Weisman, A. S., Layne, M. D., Lagna, G., & Hata, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236950 · Cited by 239
Molecular mechanisms controlling E-cadherin expression in breast cancer
Baranwal, S., & Alahari, S. K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.051 · Cited by 230
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro
Quintavalle, M., Elia, L., Condorelli, G., & Courtneidge, S. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200912096 · Cited by 211
Cohen, E. D., Ihida-Stansbury, K., Lu, M. M., Panettieri, R. A., Jones, P. L., & Morrisey, E. E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38079 · Cited by 179
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
West, J. D., Harral, J. W., Lane, K. B., Deng, Y., Ickes, B. R., Crona, D. J., Albu, S., Stewart, D. J., & Fagan, K. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90255.2008 · Cited by 137
Long, X., & Miano, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258814 · Cited by 132
Pathobiology of pulmonary arterial hypertension
Eddahibi, S., Morrell, N. W., d’Ortho, M., Naeije, R., & Adnot, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00081302 · Cited by 124
Self-citationMicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling
McDonald, R. A., Hata, A., MacLean, M. R., Morrell, N. W., & Baker, A. H. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr299 · Cited by 117
Self-citationIdentification of non-coding RNAs embracing microRNA-143/145 cluster
Iio, A., Nakagawa, Y., Hirata, I., Naoe, T., & Akao, Y. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-136 · Cited by 87
Mayorga, M. E., & Penn, M. S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01385.x · Cited by 52
Jiang, Y. Q., Luo, W., & Howe, P. H. (2009) · Oncogene · doi:10.1038/onc.2009.157 · Cited by 48
MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications
Kartha, R. V., & Subramanian, S. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9172-z · Cited by 43
Cited by
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
Self-citationGenetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
microRNAs in Cardiovascular Diseases
Condorelli, G., Latronico, M. V. G., & Cavarretta, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.050 · Cited by 375
Metadata
- Authors
- Caruso, P., Dempsie, Y., Stevens, H. C., McDonald, R. A., Long, L., Lu, R., White, K., Mair, K. M., McClure, J. D., Southwood, M., Upton, P., Xin, M., van Rooij, E., Olson, E. N., Morrell, N. W., MacLean, M. R., & Baker, A. H.
- Venue
- Circulation Research
- Published
- 2012-07-20
- Volume
- 111
- Issue
- 3
- Pages
- 290-300
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1838133438
- Cited by
- 278
- References
- 36
- FWCI
- 27.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.